cdmo.directory
← Compare landing

Dipharma vs Sussex Research Laboratories Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/sussex-research

CategoryDipharmaSussex Research Laboratories Inc.
Listed sitecdmoboth
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Bioconjugation Services
  • Translational Research
  • Discovery Research
  • Quality Control Testing
Modalities
  • Small Molecule
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Vaccine
  • Peptide
IndicationsData not yet provided.
  • Oncology
  • Infectious Disease
  • Immunology
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
  • Headquarters, Canada
CertificationsData not yet provided.
  • ISO · Identifier: ISO 9001:2015
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.